Michael Ugrumov

Publications²⁷

• Article Beliakov S. V., Blokhin V., Surkov S. A., Michael V. Ugrumov. LUHMES Cells: Phenotype Refinement and Development of an MPP+-Based Test System for Screening Antiparkinsonian Drugs // International Journal of Molecular Sciences. 2023. Vol. 24. No. 1. Article 733. doi
• Article Kolacheva A., Bannikova A., Pavlova E., Bogdanov V., Ugrumov M. Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson's Disease // International Journal of Molecular Sciences. 2023. Vol. 24. No. 1. Article 683. doi
• Article Katunina E. A., Blokhin V., Nodel M. R., Pavlova E. N., Kalinkin A. L., Kucheryanu V. G., Alekperova L., Michael V. Ugrumov. Searching for biomarkers in the blood of patients at risk of developing Parkinson's disease at the prodromal stage // International Journal of Molecular Sciences. 2023. Vol. 24. No. 3. Article 1842. doi
• Article Kolacheva A., Pavlova E., Bannikova A., Bogdanov V., Troshev D., Ugrumov M. The Gene Expression of Proteins Involved in Intercellular Signaling and Neurodegeneration in the Substantia Nigra in a Mouse Subchronic Model of Parkinson’s Disease // International Journal of Molecular Sciences. 2023. Vol. 24. No. 3. Article 3027. doi
• Article Blokhin V., Lavrova A. V., Surkov S. A., Mingazov E. R., Gretskaya N. M., Ugrumov M. A New Method for the Visualization of Living Dopaminergic Neurons and Prospects for Using It to Develop Targeted Drug Delivery to These Cells // International Journal of Molecular Sciences. 2022. Vol. 23. No. 7. Article 3678. doi
• Article Kim A., Pavlova E., Kolacheva A., Bogdanov V., Dilmukhametova L., Ugrumov M. Development of early diagnosis of Parkinson's disease on animal models based on the intranasal administration of α-methyl-p-tyrosine methyl ester in a gel system // Biomedicine and Pharmacotherapy. 2022. Vol. 150. Article 112944. doi
• Article Blokhin V., Shupik M., Gutner U., Pavlova E., Lebedev A. T., Maloshitskaya O., Bogdanov V., Ugrumov M. The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson’s Disease // Biomolecules. 2022. Vol. 12. No. 1. Article 93. doi
• Article Bogdanov V., Kim A., Nodel M., Pavlenko T., Pavlova E., Ugrumov M. A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson's Disease and Parkinsonian Mice // International Journal of Molecular Sciences. 2021. Vol. 22. No. 9. Article 4736. doi
• Article Blokhin V. E., M. V. Ugryumov. Alpha-Synuclein in the Blood of Mice in a Neurotoxic Model of Parkinson's Disease // Neurochemical Journal. 2021. Vol. 15. No. 1. P. 18-23. doi
• Article Гусев Е. И., Блохин В. Е., Вартанов С. А., Мартынов М. Ю., Катунина Е. А., Алесенко А. В., Денисова И. А., Павлова Е. Н., Полтерович В. М., Кучеряну В. Г., Шупик М. А., Нодель М. Р., Калинкин А. Л., Соколов С. А., Чубарова Т. В., Шаклеина (Лещайкина) М. В., Пронина Т. С., Угрюмов М. В. Разработка ранней диагностики болезни Паркинсона и комплексный экономический анализ эффекта от ее внедрения // Журнал неврологии и психиатрии им. С.С. Корсакова. 2021. Т. 121. № 1. С. 9-20. doi
• Article Safandeev V. V., Ugrumov M. A New Approach to Assessing the Extent of Degradation of the Nigrostriatal Dopaminergic System in an Experimental Model of Parkinson’s Disease // Neuroscience and Behavioral Physiology. 2020. Vol. 50. No. 4. P. 451-458. doi
• Article Ugrumov M. Characteristic of Dopamine-Producing System and Dopamine Receptors in the Suprachiasmatic Nucleus in Rats in Ontogenesis. // Doklady Biochemistry and Biophysics. 2020. Vol. 490. P. 34-37. doi
• Article Kurtova A. I., Dil’mukhametova L. K., Pronina T. S., Mingazov E. R., Ugrumov M. Dopamine-Producing Neurons in Rat Ontogeny: Phenotypic Features Underlying Molecular Mechanisms of Secretion and Regulation // Russian Journal of Developmental Biology. 2020. Vol. 51. No. 1. P. 57-64. doi
• Article Alieva A., Rudenok M., Filatova E., Ugrumov M. VCP expression decrease as a biomarker of preclinical and early clinical stages of Parkinson’s disease // Scientific Reports. 2020. Vol. 10. Article 827. doi
• Article Pavlova E. N., Mingazov E. R., Surkov S. A., Ugrumov M. Proteins of the Vesicular Cycle as a Marker of Neuroplasticity of Dopaminergic Neurons in the Substantia Nigra of the Brain // Doklady Biochemistry and Biophysics. 2019. Vol. 489. No. 1. P. 399-402. doi
• Article Pronina T. S., Dil’mukhametova L. K., Kurtova A. I., Ugrumov M. Synthesis of Dopamine by Non-Dopaminergic Neurons of the Rat Tuberoinfundibular System during Ontogeny // Neurochemical Journal. 2019. Vol. 13. No. 4. P. 335-343. doi
• Article Ugrumov M. Tear Fluid Catecholamines As Biomarkers of the Parkinson’s Disease: A Clinical and Experimental Study // Acta Naturae. 2019. Vol. 11. No. 4. P. 99-103. doi
• Article Kim A., Nigmatullina R., Zalyalova Z., Ugrumov M. Upgraded Methodology for the Development of Early Diagnosis of Parkinson’s Disease Based on Searching Blood Markers in Patients and Experimental Models // Molecular Neurobiology. 2019. Vol. 56. No. 5. P. 3437-3450. doi
• Article Ugrumov M. MPTP Mouse Model of Preclinical and Clinical Parkinson's Disease as an Instrument for Translational Medicine // Molecular Neurobiology. 2018. P. 1-16. doi
• Article Kozina E., Kim A., Kurina A., Ugrumov M. Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism // Neurobiology of Disease. 2017. Vol. 98. No.  Issue null. P. 108-121. doi
• Article Mingazov E. R., Khakimova G. R., Kozina E. A., Medvedev A. E., Buneeva O. A., Bazyan A. S., Ugrumov M. MPTP Mouse Model of Preclinical and Clinical Parkinson’s Disease as an Instrument for Translational Medicine // Molecular Neurobiology. 2017. P. 1-16. (in press)
• Article Bondarenko N. S., Murtazina A. R., Nikishina Y. O., Sapronova A. Y., Ugrumov M. Molecular mechanisms of synthesis of noradrenaline as an inducer of development in the adrenal glands of rats in ontogenesis // Doklady Biochemistry and Biophysics. 2017. Vol. 472. No. 1. P. 23-26. doi
• Article Bondarenko N., Dilmukhametova L., Kurina A., Murtazina A., Sapronova A., Sysoeva A., Ugrumov M. Plasticity of central and peripheral sources of noradrenaline in rats during ontogenesis // Biochemistry. Biokhimiia. 2017. Vol. 82. No. 3. P. 373-379. doi
• Article Nikishina Y., Murtazina A., Sapronova A., Melnikova V., Bondarenko N., Ugrumov M. Reciprocal humoral regulation of endocrine noradrenaline sources in perinatal development of rats // Russian Journal of Developmental Biology. 2016. Vol. 47. No. 5. P. 260-268. doi
• Article Khakimova G. R., Kozina E. A., Kucheryanu V. G., Ugrumov M. Reversible Pharmacological Induction of Motor Symptoms in MPTP-Treated Mice at the Presymptomatic Stage of Parkinsonism: Potential Use for Early Diagnosis of Parkinson’s Disease // Molecular Neurobiology. 2016. Vol. 54. No. 5. P. 3618-3632. doi
• Article Bondarenko N., Murtazina A., Dil’mukhametova L., Ikonopistseva M., Volina E., Ugrumov M. Secretory activity of the brain and peripheral organs: Spontaneous and stimulated release of noradrenaline in the ontogenesis of rats // Doklady Biochemistry and Biophysics. 2016. Vol. 467. No. 1. P. 153-156. doi
• Article Nikishina Y., Sapronova A., Ugrumov M. The effect of dopamine secreted by the brain into the systemic circulation on prolactin synthesis by the pituitary gland in ontogenesis // Acta Naturae. 2016. Vol. 8. No. 3(30). P. 111-117.